Cisplatin ototoxicity and protection: Clinical and experimental studies

319Citations
Citations of this article
242Readers
Mendeley users who have this article in their library.

Abstract

Cisplatin is a chemotherapeutic agent that is widely used to treat a variety of malignant tumors. Serious dose-limiting side effects like ototoxicity, nephrotoxicity and neurotoxicity occur with the use of this agent. This review summarizes recent important clinical and experimental investigations of cisplatin ototoxicity. It also discusses the utility of protective agents employed in patients and in experimental animals. The future strategies for limiting cisplatin ototoxicity will need to avoid interference with the therapeutic effect of cisplatin in order to enhance the quality of life of patients receiving this important anti-tumor agent. © 2009 Tohoku University Medical Press.

Cite

CITATION STYLE

APA

Rybak, L. P., Mukherjea, D., Jajoo, S., & Ramkumar, V. (2009). Cisplatin ototoxicity and protection: Clinical and experimental studies. Tohoku Journal of Experimental Medicine. https://doi.org/10.1620/tjem.219.177

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free